EP
INSM icon

Eversept Partners’s Insmed INSM Stock Holding History

Eversept Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3M Buy
96,600
+2,600
+3% +$315K 0.53% 48
2026
Q1 		$15.4M Buy
+94,000
New +$14.5M 0.81% 30

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Eversept Partners's INSM Position: Q2 2026 in Review

Eversept Partners opened a new position in Insmed (INSM) in Q2 2026: 149,209 shares worth $15.9M. The stake represents 0.83% of the portfolio and ranks #34 among its holdings. This is a return to the name: Eversept Partners previously reported a position in INSM as recently as Q3 2024.

Eversept Partners first reported a position in INSM in Q2 2024 and has held it in 3 quarters since. The position peaked at $79.5M in Q3 2024. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Eversept Partners held 149,209 shares of Insmed worth $15.9M as of Q2 2026.
  • Insmed was a new Eversept Partners position in Q2 2026.
  • Insmed made up 0.83% of Eversept Partners's portfolio in Q2 2026, its #34 holding.
  • Eversept Partners first reported a position in Insmed in Q2 2024 and has held it in 3 quarters since.
  • Eversept Partners's Insmed position peaked at $79.5M in Q3 2024.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.